ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 85 filers reported holding ACCELERON PHARMA INC in Q3 2014. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,451,000 | +33.7% | 20,052 | -2.5% | 0.02% | +40.0% |
| Q2 2021 | $2,581,000 | -5.1% | 20,565 | +2.6% | 0.02% | -16.7% |
| Q1 2021 | $2,719,000 | +1.4% | 20,049 | -4.3% | 0.02% | +5.9% |
| Q4 2020 | $2,682,000 | -14.2% | 20,960 | -24.5% | 0.02% | -26.1% |
| Q3 2020 | $3,126,000 | -2.4% | 27,775 | -17.4% | 0.02% | -8.0% |
| Q2 2020 | $3,202,000 | +31.8% | 33,611 | -48.3% | 0.02% | +316.7% |
| Q3 2017 | $2,429,000 | +20.2% | 65,051 | -2.1% | 0.01% | +20.0% |
| Q2 2017 | $2,020,000 | +11.9% | 66,474 | -2.5% | 0.01% | 0.0% |
| Q1 2017 | $1,805,000 | +6.5% | 68,182 | +2.7% | 0.01% | 0.0% |
| Q4 2016 | $1,695,000 | +59.9% | 66,406 | +89.5% | 0.01% | +66.7% |
| Q3 2014 | $1,060,000 | -16.9% | 35,038 | -6.7% | 0.00% | 0.0% |
| Q2 2014 | $1,276,000 | – | 37,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |